Abstract

Irritable bowel syndrome (IBS) frequently occurs after infectious colitis or inflammatory bowel disease in patients with complete remission. This suggests that post-inflammation-associated factors may serve a role in the pathophysiology of IBS; however, the mechanism responsible remains unclear. In the present study, the involvement of macrophages and mast cells in alteration of gastrointestinal (GI) motility was investigated in mice in the remission stage after acute colitis. C57BL/6 mice were administered 2% dextran sulfate sodium in drinking water for 5 days and their intestinal tissues were investigated at intervals for up to 24 weeks. Expression of the mannose receptor (MR) and tryptase was examined by immunohistochemistry, and the GI transit time (GITT) was measured by administration of carmine red solution. A minimal degree of inflammatory cell infiltration persisted in the colon and also the small intestine of mice in remission after colitis and the GITT was significantly shorter. The number of muscularis MR-positive macrophages was significantly increased in the small intestine of mice in remission after colitis and negatively correlated with GITT. Furthermore, results indicated that the number of muscularis tryptase-positive mast cells was significantly increased throughout the intestine of mice during the healing process after colitis and was positively correlated with GITT. The present findings suggested an increased number of macrophages and/or mast cells in the intestinal muscular layer may be associated with the pathophysiology of GI dysmotility after colitis.

Highlights

  • Irritable bowel syndrome (IBS) is a type of functional gastrointestinal disorder (FGID) characterized by symptoms such as abdominal pain or discomfort and stool irregularities, unassociated with metabolic or organic abnormalities [1,2]

  • IBS occurs frequently in patients recovering from infectious colitis, [3,4] and we have reported that IBS‐like symptoms are often observed in patients with inflammatory bowel disease (IBD) even after the bowel inflammation has been eliminated [5]

  • FGIDs frequently occur in patients after infectious colitis [3,4] endoscopic examinations reveal no apparent abnormality in the enteric lumen, suggesting that some form of cryptic molecular alteration plays a pathophysiologic role

Read more

Summary

Introduction

Irritable bowel syndrome (IBS) is a type of functional gastrointestinal disorder (FGID) characterized by symptoms such as abdominal pain or discomfort and stool irregularities, unassociated with metabolic or organic abnormalities [1,2]. IBS occurs frequently in patients recovering from infectious colitis, [3,4] and we have reported that IBS‐like symptoms are often observed in patients with inflammatory bowel disease (IBD) even after the bowel inflammation has been eliminated [5]. In such patients, despite macroscopic healing of the intestinal mucosa, IBS‐like symptoms persist. In order to clarify the pathophysiologic roles of immune cells, the investigation of mast cells and macrophages in experimental IBS model appears to be important

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call